ES2270347T3 - Composiciones farmaceuticas estabilizadas de safingol y metodos de utilizacion de las mismas. - Google Patents
Composiciones farmaceuticas estabilizadas de safingol y metodos de utilizacion de las mismas. Download PDFInfo
- Publication number
- ES2270347T3 ES2270347T3 ES04712898T ES04712898T ES2270347T3 ES 2270347 T3 ES2270347 T3 ES 2270347T3 ES 04712898 T ES04712898 T ES 04712898T ES 04712898 T ES04712898 T ES 04712898T ES 2270347 T3 ES2270347 T3 ES 2270347T3
- Authority
- ES
- Spain
- Prior art keywords
- solution
- emulsion
- sphingolipid
- dihydrosphingosine
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44953603P | 2003-02-21 | 2003-02-21 | |
| US449536P | 2003-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2270347T3 true ES2270347T3 (es) | 2007-04-01 |
Family
ID=32927531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES04712898T Expired - Lifetime ES2270347T3 (es) | 2003-02-21 | 2004-02-19 | Composiciones farmaceuticas estabilizadas de safingol y metodos de utilizacion de las mismas. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7476692B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1594488B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP4842800B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE331507T1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2516399C (cg-RX-API-DMAC10.html) |
| DE (1) | DE602004001393T2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2270347T3 (cg-RX-API-DMAC10.html) |
| MX (1) | MXPA05008860A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004075834A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2013016B8 (en) | 2006-03-29 | 2014-10-08 | Wayne State University | Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery |
| CA2817198C (en) * | 2009-11-12 | 2018-05-01 | Texas Tech University | Compositions and methods for treating hyperproliferative disorders |
| WO2015013566A1 (en) * | 2013-07-25 | 2015-01-29 | Nemucore Medical Innovations, Inc. | Nanoemulsions of hydrophobic platinum derivative |
| IT201600105201A1 (it) * | 2016-10-19 | 2018-04-19 | Nutrilinea Srl | Uso della fosfatidilserina per la prevenzione e il trattamento dei disturbi della prostata e relative composizioni farmaceutiche e nutraceutiche |
| US10034895B2 (en) * | 2017-11-30 | 2018-07-31 | Joel Steven Goldberg | Local application of D-lactic acid dimer is selectively cytotoxic when applied to cancer cells |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0716589A4 (en) * | 1993-07-23 | 1997-06-11 | Morris Herstein | COSMETIC COMPOSITION STIMULATING THE RENEWAL OF THE SKIN WITH A PROLONGED IRRITATION ELIMINATION EFFECT |
| CA2234968A1 (en) * | 1995-10-18 | 1997-04-24 | Mary Kay Inc. | Topically applied, structural cellulite treatments |
| US5635536A (en) | 1994-12-07 | 1997-06-03 | Pharmacia & Upjohn Aktiebolag | Emulsion suitable for administering a sphingolipid |
| US6368831B1 (en) * | 1998-06-29 | 2002-04-09 | Childrens Hospital Los Angeles | Treatment of hyperproliferative disorders |
| US6352844B1 (en) * | 1998-06-29 | 2002-03-05 | Childrens Hospital Los Angeles | Treatment of hyperproliferative disorders |
| JP3220434B2 (ja) | 1998-12-28 | 2001-10-22 | 花王株式会社 | 化粧料 |
| KR100343885B1 (ko) * | 1999-07-20 | 2002-07-19 | 주식회사 두산 | 파이토스핑고신의 수용액의 제조 방법 |
| KR100371491B1 (ko) * | 1999-07-27 | 2003-02-07 | 주식회사 두산 | 피부 보호용 크림조성물 |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| JP3896234B2 (ja) * | 1999-12-24 | 2007-03-22 | 花王株式会社 | 化粧料 |
| EP1287815A1 (en) * | 2001-08-31 | 2003-03-05 | Cosmoferm B.V. | Use of a sphingoid base for inhibiting ceramidase activity |
| US7846969B2 (en) | 2001-12-10 | 2010-12-07 | Kao Corporation | Ceramide emulsions |
| JP4119646B2 (ja) * | 2001-12-10 | 2008-07-16 | 花王株式会社 | セラミド類乳化物の製造法 |
| JP4220698B2 (ja) * | 2001-12-10 | 2009-02-04 | 花王株式会社 | 皮膚外用剤 |
| JP2005538156A (ja) * | 2002-09-05 | 2005-12-15 | ガルデルマ・ソシエテ・アノニム | 爪塗布用溶液 |
-
2004
- 2004-02-19 ES ES04712898T patent/ES2270347T3/es not_active Expired - Lifetime
- 2004-02-19 AT AT04712898T patent/ATE331507T1/de not_active IP Right Cessation
- 2004-02-19 DE DE602004001393T patent/DE602004001393T2/de not_active Expired - Lifetime
- 2004-02-19 JP JP2006503721A patent/JP4842800B2/ja not_active Expired - Fee Related
- 2004-02-19 EP EP04712898A patent/EP1594488B1/en not_active Expired - Lifetime
- 2004-02-19 WO PCT/US2004/004960 patent/WO2004075834A2/en not_active Ceased
- 2004-02-19 MX MXPA05008860A patent/MXPA05008860A/es active IP Right Grant
- 2004-02-19 CA CA2516399A patent/CA2516399C/en not_active Expired - Fee Related
- 2004-02-19 US US10/782,459 patent/US7476692B2/en not_active Expired - Lifetime
-
2010
- 2010-12-27 JP JP2010290577A patent/JP2011126886A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2516399A1 (en) | 2004-09-10 |
| JP4842800B2 (ja) | 2011-12-21 |
| JP2011126886A (ja) | 2011-06-30 |
| US20050187186A1 (en) | 2005-08-25 |
| DE602004001393D1 (de) | 2006-08-10 |
| JP2006518743A (ja) | 2006-08-17 |
| DE602004001393T2 (de) | 2007-06-14 |
| US7476692B2 (en) | 2009-01-13 |
| WO2004075834A2 (en) | 2004-09-10 |
| EP1594488B1 (en) | 2006-06-28 |
| CA2516399C (en) | 2013-05-14 |
| MXPA05008860A (es) | 2005-10-05 |
| ATE331507T1 (de) | 2006-07-15 |
| WO2004075834A3 (en) | 2005-03-24 |
| EP1594488A2 (en) | 2005-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6404242B2 (ja) | がんの治療のための併用療法としてのエリブリンおよびレンバチニブの使用 | |
| ES2813340T3 (es) | Método de tratamiento del cáncer | |
| ES2909741T3 (es) | Tratamiento del cáncer | |
| BR102020023664A2 (pt) | Composições compreendendo canabidiol e flavononas | |
| CN112789059A (zh) | 氨基酸类营养素的应用以及包含它的药物组合物 | |
| MX2013005196A (es) | Metodos para tratamiento del cancer. | |
| US20240058267A1 (en) | Slurry and solution compositions | |
| WO2012004438A1 (es) | Una formulación farmacéutica inyectable de melfalano | |
| BR112020003349A2 (pt) | composições e métodos para modular o crescimento capilar | |
| US20220023288A1 (en) | Pharmaceutical solution for oral dosage | |
| EP2956131B1 (en) | Treatment of klebsiella pneumoniae with liposomally formulated glutathione | |
| JP2011126886A (ja) | サフィンゴールの医薬組成物およびその使用方法 | |
| CN110870869A (zh) | 包含糖类营养素和常规无效化合物的药物组合物及其应用 | |
| BR112020009141A2 (pt) | método para tratar câncer de mama num indivíduo | |
| CN110870858A (zh) | 包含有机酸酸化剂和常规无效化合物的药物组合物及其应用 | |
| JP2025532719A (ja) | 腫瘍血管破壊用医薬組成物 | |
| CN112438942A (zh) | 包含碱化剂及其协同物的药物组合物及其应用 | |
| CN110870918A (zh) | 包含氨基酸类营养素和抗肿瘤化疗药物的药物组合物及其应用 | |
| WO2023215323A1 (en) | Intranasal baclofen | |
| US20060142254A1 (en) | Antipyretic preparation containing xylitol | |
| BRPI0713094A2 (pt) | métodos de administração de droga | |
| JP2011513378A (ja) | ベリノスタットの長期持続注入を用いた治療方法 | |
| ES2990173B2 (es) | Complejo de inclusion cuaternario de hidroxitirosol, triptofano, arginina y gluconato de zinc, metodo de obtencion y uso | |
| CN113230420A (zh) | 包含亚甲蓝类活体染料的水基乳剂、该乳剂的应用以及包含该乳剂的药物组合物 | |
| JP6924431B2 (ja) | ヒトを除く哺乳動物への薬剤の投与方法 |